Alamar Biosciences, Inc. (ALMR) has filed to raise capital via an IPO that may exceed $100 million, according to an S-1 registration statement. The company has developed a protein biomarker analysis ...
Weight loss drug developer Kailera Therapeutics (KLRA) and Alamar Biosciences (ALMR), a commercial-stage proteomics company, filed for their respective U.S. initial public offerings with the SEC on ...
SHANGHAI, April 20, 2026 /PRNewswire/ -- Alamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully listed on the NASDAQ Stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results